An in vivo evaluation of the antifibrotic potential of inulin against bile duct ligation-induced liver fibrosis

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 0

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-2_012

تاریخ نمایه سازی: 7 بهمن 1404

چکیده مقاله:

Objective(s): Hepatic fibrosis is a major cause of liver-related mortality worldwide. This study evaluated the hepatoprotective and antifibrotic effects of inulin, a natural polysaccharide, in a rat model of cholestasis induced by bile duct ligation (BDL).Materials and Methods: Thirty male Wistar rats (۲۳۰–۲۵۰ g) were randomly divided into six groups: control, sham, inulin (۲۰۰ mg/kg), BDL, and BDL+ inulin (۱۰۰ and ۲۰۰ mg/kg). Inulin was orally administered for ۳۰ days after BDL. Serum liver enzyme levels, bilirubin, and lipid profiles were measured. Liver tissues were analyzed for oxidative stress markers (GPx, MDA), fibrogenic mediators (TGF-β۱, α-SMA) via immunohistochemistry, and FXR levels by ELISA. Histological changes were evaluated by ELISA and Masson’s trichrome staining.Results: At ۲۰۰ mg/kg, inulin significantly reversed the BDL-induced increases in serum liver enzymes (AST, ALT, and ALP), total bilirubin, and cholesterol (P<۰.۰۰۱ vs BDL group). Hepatic GPx and FXR levels were significantly increased (P<۰.۰۰۱ vs BDL group), while MDA levels were decreased (P<۰.۰۰۱ vs BDL group). Inulin markedly suppressed the expression of TGF-β۱ and α-SMA (P<۰.۰۱ vs BDL group). Histopathological evaluation showed notable improvement in liver architecture, with reduced fibrosis and necrosis (P<۰.۰۰۱ vs BDL group). Conclusion: These findings suggest that inulin may exert antifibrotic effects through its anti-oxidant activity, ultimately reducing the expression of fibrogenic markers. This study presents strong histological evidence to support the hepatoprotective role of inulin.

نویسندگان

Yasaman Habibian-Fard

Department of Pharmacology and Toxicology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Mahsa Ale-Ebrahim

Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Parvaneh Mohseni-Moghaddam

Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Shadi Sarahroodi

Department of Pharmacology and Toxicology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Pejman Mortazavi

Department of Pathology, Faculty of Specialized Veterinary Science and Research Branch, Islamic Azad University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and ...
  • Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate ...
  • Chen WY, Chen CJ, Liao JW, Mao FC. Chromium attenuates ...
  • Cruz A, Padillo FJ, Granados J, Túnez I, Muñoz MC, ...
  • Han JM, Kim HG, Choi MK, Lee JS, Park HJ, ...
  • Karkhaneh L, Yaghmaei P, Parivar K, Sadeghizadeh M, Ebrahim-Habibi A. ...
  • Singh H, Sidhu S, Chopra K, Khan MU. Hepatoprotective effect ...
  • Morry J, Ngamcherdtrakul W, Yantasee W. Oxidative stress in cancer ...
  • Casini A, Pinzani M, Milani S, Grappone C, Galli G, ...
  • Ramadori G, Knittel T, Odenthal M, Schwögler S, Neubauer K, ...
  • Sawdey MS, Loskutoff DJ. Regulation of murine type ۱ plasminogen ...
  • Inagaki Y, Okazaki I. Emerging insights into transforming growth factor ...
  • Adorini L, Trauner M. FXR agonists in NASH treatment. J ...
  • Pan PH, Wang YY, Lin SY, Liao SL, Chen YF, ...
  • Apolinário AC, de Lima Damasceno BPG, de Macêdo Beltrão NE, ...
  • Liu J, Lu JF, Wen XY, Kan J, Jin CH. ...
  • Barbero-Becerra V, Juárez-Hernández E, Chávez-Tapia NC, Uribe M. Inulin as ...
  • Kalantari H, Asadmasjedi N, Abyaz Mr, Mahdavinia M, Mohammadtaghvaei N. ...
  • Sugatani J, Wada T, Osabe M, Yamakawa K, Yoshinari K, ...
  • Uchinami H, Seki E, Brenner DA, D’Armiento J. Loss of ...
  • Gross Jr JB, Reichen J, Zeltner TB, Zimmermann A. The ...
  • Rifai N. Tietz textbook of clinical chemistry and molecular diagnostics-e-book: ...
  • Moss D. Clinical enzymology. Nature ۱۹۷۱;۲۳۳:۵۰۵-۵۰۵ ...
  • Sant’Anna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O. ...
  • French SW, Miyamoto K, Ohta Y, Geoffrion Y. Pathogenesis of ...
  • Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World ...
  • Sokol RJ, Straka MS, Dahl R, Devereaux MW, Yerushalmi B, ...
  • Ale-Ebrahim M, Eidi A, Mortazavi P, Tavangar SM, Minaei Tehrani ...
  • Ramaiah SK. A toxicologist guide to the diagnostic interpretation of ...
  • Javadi F, Ale-Ebrahim M, Mohseni-Moghaddam P, Mortazavi P, Mousavi Z, ...
  • Du H, Zhao A, Wang Q, Yang X, Ren D. ...
  • Bao T, He F, Zhang X, Zhu L, Wang Z, ...
  • Yang X, He F, Zhang Y, Xue J, Li K, ...
  • Chong CYL, Orr D, Plank LD, Vatanen T, O’Sullivan JM, ...
  • Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. ...
  • Catalá A. Lipid peroxidation modifies the picture of membranes from ...
  • Salehi V, Malekiasl H, Azizi M, Nouripour-Sisakht S, Gharaghani M, ...
  • Sadeghi H, Azarmehr N, Razmkhah F, Sadeghi H, Danaei N, ...
  • Nabil MAH, Hnaa AH, Hanaa MS, Amr MM. A promising ...
  • Kawasoe J, Uchida Y, Kawamoto H, Miyauchi T, Watanabe T, ...
  • Ji H, Jiang JY, Xu Z, Kroeger EA, Lee SS, ...
  • Longo M, Crosignani A, Podda M. Hyperlipidemia in chronic cholestatic ...
  • Delgado-Villa MJ, Ojeda ML, Rubio JM, Murillo ML, Sánchez OC. ...
  • Nuño‐Lámbarri N, Barbero‐Becerra VJ, Uribe M, Chávez‐Tapia NC. Elevated cholesterol ...
  • Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, ...
  • Sugatani J, Osabe M, Wada T, Yamakawa K, Yamazaki Y, ...
  • Hao H, Cao L, Jiang C, Che Y, Zhang S, ...
  • Wang YD, Chen WD, Wang M, Yu D, Forman BM, ...
  • Khan RS, Bril F, Cusi K, Newsome PN. Modulation of ...
  • Chávez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid ...
  • Alipour MR, Jeddi S, Karimi‐Sales E. Trans‐Chalcone inhibits high‐fat diet‐induced ...
  • Wang R, Ren Y, Bao T, Wang T, Li Y, ...
  • Carino A, Biagioli M, Marchianò S, Scarpelli P, Zampella A, ...
  • Ji K, Zhang M, Du L, Liu Y, Xu C, ...
  • Liu RM, Desai LP. Reciprocal regulation of TGF-β and reactive ...
  • Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, ...
  • Chan EC, Peshavariya HM, Liu GS, Jiang F, Lim SY, ...
  • نمایش کامل مراجع